Business Context and Reporting Period
This Form 8-K filing by Phreesia, Inc. (PHR) is dated June 10, 2020. The report discloses the entry into a material definitive agreement with Allscripts Healthcare, LLC, specifically the First Amendment to their Strategic Alliance Agreement, effective July 1, 2020.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a contractual amendment rather than financial performance data.
Material Changes
The primary material change is the amendment of the Strategic Alliance Agreement with Allscripts Healthcare, LLC. Key modifications include:
- Adjustments to pricing, fee terms, and invoicing procedures.
- Extension of the initial term until June 30, 2025.
- Implementation of automatic renewals for successive one-year terms following the initial term.
Outlook, Risks, and Contingencies
The Amended Agreement includes specific termination provisions that serve as material contingencies:
- Termination for Convenience: Either party may terminate with one year's prior written notice.
- Immediate Termination: Allowed if Phreesia is determined ineligible to participate in federal healthcare programs or upon certain change of control transactions.
- Breach and Insolvency: Termination is permitted upon an uncured material breach or the insolvency of the other party.
The full text of the Amendment is scheduled to be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ending July 31, 2020.
Investor Verification Checklist
- Verify the specific details of the amended pricing and fee terms in the full text of the Amendment.
- Monitor the upcoming Form 10-Q for the quarter ending July 31, 2020, for the complete agreement text.
- Assess the impact of the extended term (through 2025) on future revenue stability.
- Review the conditions under which the agreement can be terminated immediately, particularly regarding federal healthcare program eligibility.